The advantage of residualizing radiolabels for targeting B-cell lymphomas with a radiolabeled anti-CD22 monoclonal antibody. [electronic resource]
Producer: 19970529Description: 429-35 p. digitalISSN:- 0020-7136
- Animals
- Antibodies, Monoclonal -- pharmacokinetics
- Antigens, CD -- immunology
- Antigens, Differentiation, B-Lymphocyte -- immunology
- Cell Adhesion Molecules -- immunology
- Humans
- Indium Radioisotopes -- pharmacokinetics
- Iodine Radioisotopes -- pharmacokinetics
- Lectins
- Metabolic Clearance Rate
- Mice
- Mice, Nude
- Pentetic Acid -- pharmacokinetics
- Radioimmunodetection -- methods
- Sialic Acid Binding Ig-like Lectin 2
- Time Factors
- Transplantation, Heterologous
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.